ISRG vs ABT Comparison: AI Score, Valuation, Performance and Upside
ISRG holds the edge across 4 of 5 key metrics in this comparison. ISRG has delivered stronger 1-year price return (-20.89% vs -33.96%), though ABT trades at the lower forward P/E (14.59x vs 34.51x). ISRG leads on both revenue growth (23.00%) and operating margin (30.87%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for ISRG (+38.92%) than for ABT (+31.82%).
| Metric | ISRG | ABT |
|---|---|---|
| AI score | 50.1 | 48.2 |
| AI rank | #416 | #531 |
| Latest close | $402.95 | $87.83 |
| 1M return | -8.02% | +0.48% |
| 6M return | -29.61% | -29.99% |
| 1Y return | -20.89% | -33.96% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | ISRG | ABT |
|---|---|---|
| 1Y ago | $7.82K (-21.8%) started 2025-06-23 | $6.59K (-34.1%) started 2025-06-23 |
| 5Y ago | $13.35K (+33.5%) started 2021-06-23 | $9.21K (-7.9%) started 2021-06-23 |
| 10Y ago | $54.84K (+448.4%) started 2016-06-23 | $31.39K (+213.9%) started 2016-06-23 |
Hypothetical — past performance does not guarantee future results.
| Metric | ISRG | ABT |
|---|---|---|
| Market cap | $144.07B | $153.99B |
| Trailing P/E | 49.49 | 24.76 |
| Forward P/E | 34.51 | 14.59 |
| Price/Sales | 22.91 | 5.49 |
| EV/Revenue | 13.20 | 4.02 |
| Analyst target | $565.08 | $116.54 |
| Target upside | +38.92% | +31.82% |
| Metric | ISRG | ABT |
|---|---|---|
| Revenue growth | 23.00% | 7.80% |
| Earnings growth | 18.80% | -19.70% |
| EPS growth | +18.80% | -19.70% |
| FCF margin | +21.30% | +14.05% |
| Operating margin | 30.87% | 13.47% |
| Profit margin | 28.15% | 13.90% |
| ROIC proxy | 17.23% | 12.33% |
| Return on equity | 17.23% | 12.33% |
| Dividend yield | N/A | 2.85% |
| Beta | 1.45 | 0.62 |
| Debt/equity | 0.95 | 64.77 |
| Current ratio | 4.61 | 1.39 |
| Quick ratio | 3.26 | 0.84 |
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | ISRG | ABT |
|---|---|---|---|
| 1Y | Growth | -21.77% | -34.09% |
| CAGR | -21.84% | -34.19% | |
| Sharpe ratio | -0.79 | -1.75 | |
| Max drawdown | 32.16% | 40.21% | |
| Max daily drop | 6.67% | 10.04% | |
| Max wkly drop | 8.79% | 13.11% | |
| 5Y | Growth | +33.51% | -14.70% |
| CAGR | +5.95% | -3.13% | |
| Sharpe ratio | 0.21 | -0.24 | |
| Max drawdown | 49.90% | 40.85% | |
| Max daily drop | 14.34% | 10.04% | |
| Max wkly drop | 22.30% | 13.11% | |
| 10Y | Growth | +448.38% | +161.92% |
| CAGR | +18.56% | +10.11% | |
| Sharpe ratio | 0.55 | 0.34 | |
| Max drawdown | 49.90% | 40.85% | |
| Max daily drop | 14.34% | 10.04% | |
| Max wkly drop | 22.30% | 16.72% |
| Category | ISRG | ABT |
|---|---|---|
| Company | ISRG | ABT |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Devices |
| Core business | N/A | N/A |
| Investor focus | N/A | N/A |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.